quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:05:00·25d
PRRelease
Sight Sciences Inc. logo

Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury's Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent

SGHT· Sight Sciences Inc.
Health Care
Original source

Companies

  • SGHT
    Sight Sciences Inc.
    Health Care

Recent analyst ratings

  • Jan 5UpdatePiper Sandler$9.00
  • Aug 8UpdateLake Street$5.00
  • Dec 6UpdateUBS$5.50
  • Nov 4UpdateLake Street$5.00
  • Aug 21UpdateLake Street$10.00
  • Sep 12UpdateBofA Securities$4.50

Related

  • SEC1d
    Sight Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR1d
    Sight Sciences Announces the Release of its Sustainability Report
  • SEC1d
    SEC Form DEFA14A filed by Sight Sciences Inc.
  • SEC1d
    SEC Form DEF 14A filed by Sight Sciences Inc.
  • PR2d
    Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026
  • INSIDER14d
    SEC Form 4 filed by Rodberg James
  • INSIDER14d
    SEC Form 4 filed by Hayden Jeremy B.
  • INSIDER20d
    SEC Form 4 filed by Bauerlein Alison
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022